That would be a 205% YoY GR back to back. I have been thinking about that a lot. I wonder about the kind of valuation multiple LFMD could get next February 2022 after the market confirms such an incredible growth power.
ShapiroMD just got transformed into a subscribers base business model. Imagine all the recurring contribution for the upcoming years, specially with the new patented line of products for women. Did you know that women customers represent 80% of the revenue?
The LSS revenue just got increased by 61.9%. Just like that, no need to go through all the process to invent and get a new brand going. And this SaaS vertical is very successful and worth a lot more than the market cares to value. The Market will find out in a few quarters.
For the LSS segment: (82.6 - 51) / 51 = 61.9% of a $18M ARR and fast growing business and the CEO only paid $350K for this extra piece of the business and $750 to $850 for the first 51%.
This is the kind of deals that I am getting used to seeing from Justin Schreiber, CVLB's CEO.
And there are so many other smaller things that when put together they build the foundation of this year's expected growth.
I wasn't expecting the LifeMD brand so soon either and with a $260B TAM. This PR was just fabulous.
News 
Market Data 
Discover 
